Moreover, recent resistance profiling in gastric cancer has suggested that Wnt beta catenin activation and ECM remodeling cooperate to generate a drug tolerant state [108], which aligns with our findings for CTNNB1 and COL4A1. This evidence concerns the gene CTNNB1 and gastric cancer.